Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ASND —
ASCENDIS PHARMA A/S
CUSIP: 04351P101 · Held by 2 superinvestors · Combined value: $127,971,081
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $127,712,847 | 598,916 | ADD | +469,076 |
| 2 | Polen Capital | 0.0% | $258,234 | 1,211 | REDUCE | -1,555 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +469,076 | +361.3% |
| Polen Capital | REDUCE | -1,555 | -56.2% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Polen Capital | ADD | +47 | +1.7% |
| Ken Griffin | REDUCE | -481,202 | -78.8% |
Who Owns ASND? Superinvestor Holdings
ASCENDIS PHARMA A/S is held by 2 tracked superinvestors, with a combined position value of $128 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Polen Capital (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.